You are here

  • Home
  • Archive
  • Volume 26, Issue 2
  • Real-time continuous glucose monitoring is not inferior to current standard of care for inpatient glycaemic monitoring and may decrease recurrent hypoglycaemic events

Article Text

Article menu
Download PDFPDF
Commentary
Adult nursing
Real-time continuous glucose monitoring is not inferior to current standard of care for inpatient glycaemic monitoring and may decrease recurrent hypoglycaemic events
  1. Jane Fletcher1,
  2. David J T Campbell2
  1. 1 Community Health Sciences, University of Calgary, Calgary, Alberta, Canada
  2. 2 Medicine, Community Health Sciences and Cardiac Sciences, University of Calgary, Calgary, Alberta, Canada
  1. Correspondence to Dr David J T Campbell, Community Health Sciences, University of Calgary, Calgary, AB T2N 4Z6, Canada; dcampbel{at}ucalgary.ca

https://doi.org/10.1136/ebnurs-2022-103596

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: Spanakis EK, Urrutia A, Galindo RJ, Vellanki P, Migdal AL, Davis G, Fayfman M, Idrees T, Pasquel FJ, Coronado WZ, Albury B, Moreno E, Singh LG, Marcano I, Lizama S, Gothong C, Munir K, Chesney C, Maguire R, Scott WH, Perez-Guzman MC, Cardona S, Peng L, Umpierrez GE. Continuous Glucose Monitoring-Guided Insulin Administration in Hospitalized Patients With Diabetes: A Randomized Clinical Trial. Diabetes Care. 2022 Oct 1;45(10):2369–2375. doi: 10.2337/dc22-0716. PMID: 35984478.

    Implications for practice and research

    • Continuous glucose monitoring (CGM) devices are not inferior to point-of-care capillary glucose testing for inpatient glycaemic monitoring.

    • CGM devices could potentially reduce hypoglycaemic events in hospital, but require more research and training for acceptability in use.

    Context

    Diabetes is a common metabolic disorder, present in more than 451 million people worldwide.1 The established practice for inpatient glycaemic monitoring when an individual whose diabetes is treated with basal-bolus insulin therapy is admitted to hospital is to use daily multiple bedside point-of-care (POC) capillary glucose testing. Guidelines recommend that POC testing …

    View Full Text

    Footnotes

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Commissioned; internally peer reviewed.